Rekombinanter EpCAM (Oportuzumab Biosimilar) Antikörper
Research Grade
Reaktivität: Human
ELISA
Wirt: Mammalian Cells
Monoclonal
unconjugated
scFv fragment
Recombinant Antibody
-
- Target
- EpCAM (Oportuzumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Fragment
- scFv fragment
- Reaktivität
- Human
- Wirt
-
Mammalian Cells
- Klonalität
- Monoklonal
- Applikation
- ELISA
- Verwendungszweck
- Oportuzumab Biosimilar - Anti-EPCAM, CD326 mAb
- Produktmerkmale
- Antibody Type: scFv-kappa-heavy
- Güteklasse
- Research Grade
- Isotyp
- Kappa
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS pH 7.5
- Lagerung
- -80 °C
- Informationen zur Lagerung
- store at -80°C
-
- Target
- EpCAM (Oportuzumab Biosimilar)
- Substanzklasse
- Biosimilar
- Hintergrund
-
VB4-845
Oportuzumab monatox is an antineoplastic. Chemically, oportuzumab is a single chain variable fragment of a monoclonal antibody which binds to epithelial cell adhesion molecule (EpCAM, the tumor-associated calcium signal transducer 1). Oportuzumab is fused with Pseudomonas aeruginosa exotoxin A (which is reflected by the monatox in the drug's name). - CAS-Nummer
- 945228-48-8
-
Sie sind hier:
